✦ LIBER ✦

Estrogen Receptor Mutations in Breast Cancer--New Focus on an Old Target

✍ Scribed by Segal, C. V.; Dowsett, M.

Book ID: 121717110
Publisher: American Association for Cancer Research
Year: 2014
Tongue: English
Weight: 350 KB
Volume: 20
Category: Article
ISSN: 1078-0432
DOI: 10.1158/1078-0432.ccr-14-0067

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

BCL-2: A New Therapeutic Target in Estro

BCL-2: A New Therapeutic Target in Estrogen Receptor-Positive Breast Cancer?

✍ Martin, Lesley-Ann; Dowsett, Mitch 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 398 KB

Understanding the estrogen receptor sign

Understanding the estrogen receptor signaling pathway: focus on current endocrine agents for breast cancer in postmenopausal women

✍ Adam M. Brufsky 📂 Article 📅 2011 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 287 KB

Advances in breast cancer treatment and

Advances in breast cancer treatment and prevention: preclinical studies on aromatase inhibitors and new selective estrogen receptor modulators (SERMs)

✍ Rachel Schiff, Gary C Chamness, Powel H Brown 📂 Article 📅 2003 🏛 BioMed Central 🌐 English ⚖ 55 KB

5-HT 1A Receptor: An Old Target as a New

5-HT 1A Receptor: An Old Target as a New Attractive Tool in Drug Discovery from Central Nervous System to Cancer

✍ Fiorino, Ferdinando; Severino, Beatrice; Magli, Elisa; Ciano, Antonio; Caliendo, 📂 Article 📅 2013 🏛 American Chemical Society 🌐 English ⚖ 744 KB

Nuclear-encoded mitochondrial MTO1 and M

Nuclear-encoded mitochondrial MTO1 and MRPL41 are regulated in an opposite epigenetic mode based on estrogen receptor status in breast cancer

✍ Tae Woo Kim,Byungtak Kim,Ju Hee Kim,Seongeun Kang,Sung-Bin Park… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 361 KB

Estrogen receptors (ER) in human breast

Estrogen receptors (ER) in human breast cancer. The significance of a new prognostic factor based on both ER protein and ER mRNA contents

✍ Marianne Gotteland; Evelyne May; Françoise May-Levin; Geneviève Contesso; Jean-C 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 843 KB

Background. The response to endocrine therapy is not entirely predictable from the estrogen receptor (ER) and progesterone receptor (PgR) status of primary breast tumors. The authors previously proposed a new prognostic factor, ER.R, which was based on both ER protein and mRNA levels. A previous ana